S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Phase 2 Completed
240 enrolled 14 charts
TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study
Phase 2 Completed
42 enrolled 12 charts
A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer
Phase 2 Terminated
180 enrolled 16 charts
Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer
Phase 2 Completed
100 enrolled 13 charts
A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment
Phase 1/2 Completed
111 enrolled 22 charts
Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab
Phase 2 Completed
16 enrolled 11 charts
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase 2 Completed
247 enrolled 10 charts
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy
Phase 2 Completed
136 enrolled 13 charts
OMEGA
Phase 2 Completed
62 enrolled 6 charts
Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon
Phase 2 Terminated
7 enrolled 5 charts
PIMABI
Phase 2 Completed
65 enrolled 18 charts
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Phase NA Terminated
3 enrolled 8 charts
Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma
Phase 1/2 Completed
52 enrolled 13 charts
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
Phase 3 Completed
3,397 enrolled 24 charts
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Completed
2,334 enrolled 9 charts
Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer
Phase 2 Completed
28 enrolled 11 charts
A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer
Phase 2 Terminated
19 enrolled 32 charts
SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial
Phase 2 Completed
266 enrolled 17 charts
PARAGON
Phase 1/2 Terminated
4 enrolled 5 charts
FC-4
Phase 2 Terminated
4 enrolled 9 charts
Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX
Phase 2 Completed
54 enrolled 7 charts
Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
Phase 2 Terminated
25 enrolled 10 charts
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Phase 2 Terminated
5 enrolled 5 charts
Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)
Phase 2 Terminated
65 enrolled 8 charts
A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRI
Phase 2 Terminated
11 enrolled 8 charts
Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer
Phase 2 Terminated
1 enrolled 2 charts
Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy
Phase 2 Completed
35 enrolled 7 charts
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
Phase 2 Completed
67 enrolled 15 charts
STEPP
Phase 2 Completed
95 enrolled 23 charts
Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer
Phase 1/2 Completed
17 enrolled 7 charts
A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)
Phase 1 Completed
6 enrolled 12 charts
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
Phase 3 Terminated
72 enrolled 15 charts